A Phase I Trial of ZIO-101 in Solid Tumors
NCT00591396 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2012-07-19
Summary
A Phase I Trial of ZIO-101 (Darinaparsin) in Solid Tumors
Conditions
Interventions
- DRUG
-
ZIO-101 (Darinaparsin)
Dose Escalation of ZIO-101 (Darinaparsin) given daily for five consecutive days to be repeated every 28 days for up to six months
Sponsors & Collaborators
-
Alaunos Therapeutics
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors
NCT05631327 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of DS3610a in Participants With Advanced Solid Tumor
NCT07159126 ·Status: RECRUITING ·Phase: PHASE1
-
First in Human Study of M1069 in Advanced Solid Tumors
NCT05198349 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors
NCT02667873 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
NCT05593094 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors
NCT00842335 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors
NCT05653661 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of DM001 in Patients With Advanced Solid Tumors
NCT06475937 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Dasatinib in Patients With Advanced Solid Tumors
NCT00162214 ·Status: TERMINATED ·Phase: PHASE1
-
Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors
NCT02688101 ·Status: COMPLETED ·Phase: PHASE1
-
AS703569 Phase I in Patients With Solid Tumours
NCT00391521 ·Status: COMPLETED ·Phase: PHASE1
-
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
NCT03401385 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
NCT05785741 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
NCT00608361 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors
NCT05911464 ·Status: RECRUITING ·Phase: PHASE1
-
A Trial of ZL-1201 in Subjects With Advanced Cancer
NCT04257617 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Oral DFP-11207 in Solid Tumors
NCT02171221 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
NCT05765851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
NCT03416816 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors
NCT05258266 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
NCT02517398 ·Status: COMPLETED ·Phase: PHASE1
-
SB-743921 In Patients With Solid Tumors
NCT00136513 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
NCT05898399 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
BMS-214662 in Treating Patients With Solid Tumors
NCT00005973 ·Status: COMPLETED ·Phase: PHASE1
-
AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours
NCT00704366 ·Status: COMPLETED ·Phase: PHASE1